Education
About Us
Working with TipRanks
Follow Us
Biotest AG (DE:BIO)
HAMBURG:BIO
BIO Stock Chart & Stats
€38.00
€0.40(0.96%)
At close: 4:00 PM EST
€38.00
€0.40(0.96%)
Day’s Range― - ―
52-Week Range€35.00 - €45.60
Previous CloseN/A
Volume121.00
Average Volume (3M)73.00
Market Cap
€1.31B
Enterprise Value€2.18B
Total Cash (Recent Filing)€119.50M
Total Debt (Recent Filing)€597.20M
Price to Earnings (P/E)64.1
Beta-0.12
Next Earnings
Nov 10, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 03, 2025Dividend Yield0.11%
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,785,727
10 Day Avg. Volume62
30 Day Avg. Volume73
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Biotest News
BIO FAQ
What was Biotest AG’s price range in the past 12 months?
Biotest AG lowest stock price was €35.00 and its highest was €45.60 in the past 12 months.
What is Biotest AG’s market cap?
Biotest AG’s market cap is €1.31B.
When is Biotest AG’s upcoming earnings report date?
Biotest AG’s upcoming earnings report date is Nov 10, 2025 which is in 16 days.
How were Biotest AG’s earnings last quarter?
Currently, no data Available
Is Biotest AG overvalued?
According to Wall Street analysts Biotest AG’s price is currently Overvalued.
Does Biotest AG pay dividends?
Biotest AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 0.11%. See more information on Biotest AG dividends here
What is Biotest AG’s EPS estimate?
Biotest AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotest AG have?
Biotest AG has 19,785,727 shares outstanding.
What happened to Biotest AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biotest AG?
Currently, no hedge funds are holding shares in DE:BIO
Biotest Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.09%
Trailing 12-Months
Company Description
Biotest AG
Biotest AG is a global biotechnology company headquartered in Germany, specializing in the development, production, and marketing of immunology and hematology products. The company focuses on therapies derived from human blood plasma, particularly for treating immune deficiencies, hemophilia, and other blood-related disorders. Key products include immunoglobulins, clotting factors, and albumin, which are essential for various medical treatments.
Technical Analysis
Eckert & Ziegler Strahlen und Medizintechnik
―
Epigenomics
―
Evotec
―
Medios AG
―
Formycon AG
―